Effect of Baseline RDW and Troponin Levels on Prognosis in Patients with Acute Chest Pain

Introduction: Red cell distribution width (RDW) is a measure of the mean corpuscular/erythrocyte volume. The aim of this study was to investigate the effect of RDW levels on the prognosis in patients with elevated levels of troponin I in the emergency department with chest pain. Materials and methods: The study included 3,922 patients aged over 18 years who presented to the emergency department with the complaint of chest pain between August 1, 2018 and August 1, 2019. Troponin values and RDW levels were compared to determine the ability to diagnose acute ischemic heart disease and determin the prognosis in these patients. Results: The median RDW was 13.3 (IQR 1.20) in patients with normal troponin and 13.3 (IQR 1.40) in patients with elevated troponin (p = 0.001), but there was no difference in clinical outcomes between the groups. There was no significant difference in RDW between the patients discharged from the emergency department, those discharged from the hospital (good outcome) and those that required intensive care or died (poor outcome) (p > 0.05). Conclusion: RDW levels may vary in patients with elevated troponin values and acute ischemia, but this has no affect on clinical outcomes.

Chest pain, Myocardial infarction, RDW

[1] Dursun M, Cimen S, Sulukaya M, et al. The predictive value of red cell distribution width on erectile dysfunction. Andrologia. 2019;5:13374.

[2] Fava C, Cattazzo F, Hu Z, et al. The role of red blood cell distribution width (RDW) in cardiovascular risk assessment: useful or hype? Ann Transl Med. 2019;7:581.

[3] Parizadeh SM, Jafarzadeh-Esfehani R, Bahreyni A, et al. The diagnostic and prognostic value of red cell distribution width in cardiovascular disease; current status and prospective. BioFactors, 2019;4:507-516.

[4] Payne RA. Cardiovascular risk. Br J Clin Pharmacol. 2012;74: 396-410.

[5] Wu T, Zheng Y, Hou X, et al. Red blood cell distribution width as long-term prognostic markers in patients with coronary artery disease undergoing percutaneous coronary intervention. Lipids Health Dis. 2019;18:140.

[6] Aksu H, Ozer O, Unal H, et al. Significance of mean platelet volume on prognosis of patients with and without aspirin resistance in settings of non-ST-segment elevated acute coronary syndromes. Blood Coagul Fibrinolysis. 2009;20:686-693.

[7] Troughton JA, Woodside JV, Young IS, et al. PRIME Study Group. Bilirubin and coronary heart disease risk in the prospective epidemi-ological study of myocardial infarction (PRIME). Eur J Cardiovasc PrevRehabil. 2007;14:79-84.

[8] Salvatori M, Formiga F, Moreno-Gonzales R, et al. Red blood cell distribution width as a prognostic factor of mortality in elderly patients firstly hospitalized due to heart failure. Kardiol Pol. 2019;6:632-638.

[9] Wołowiec Ł, Rogowicz D, Banach J, et al. Prognostic significance of red cell distribution width and other red cell parameters in patients with chronic heart failure during two years of follow-up. Kardiol Pol. 2016;74:657-664.

[10] Akça HŞ, Koylu R, Akıllı NB, et al. Effect of Ionized Calcium Level on the Prognosis and Mortality of Patients with Pulmonary Embolism. American Journal of Internal Medicine. 2018;1:20-24.

[11] Poz D, De Falco E, Pisano C, et al. Diagnostic and prognostic relevance of Red blood cell distribution width for vascular aging and cardiovascular diseases. Rejuvenation Research. 2018;22:146-162.

[12] Akilli NB, Yortanlı M, Mutlu H, et al. Prognostic importance of neutrophil-lymphocyte ratio in critically ill patients: short- and long-term outcomes, Am J Emerg Med. 2014;32:1476-1480.

[13] Monteiro Junior J G de M, De Oliveira Cipriano Torres D, Filho D C S. Hematological parameters as prognostic biomarkers in patients with cardiovascular diseases. Curr Cardiol Rev. 2019;15:274-282.

[14] Wendland AE, Farias MG, Manfroi WC. Volume plaquetáriomédio e doença cardiovascular. J BrasileiroPatologiamedicina Laboratorial. 2009;45:371-378.

[15] Lippi G, Salvagno GL, Guidi GC. Red blood cell distribution width is significantly associated with aging and gender. Clin Chem Lab Med. 2014;52:197-199.

[16] Alis R, Fuster O, Rivera L, et al. Influence of age and gender on red blood cell distribution width. Clin Chem Lab Med. 2015;53:25-28.

[17] Abrahan LL, Ramos JDA, Cunanan EL, et al. Red Cell Distribution Width and Mortality in Patients With Acute Coronary Syndrome: A Meta-Analysis on Prognosis. Cardiol Res. 2018;9:144-152.

[18] Cheng CK, Chan J, Cembrowski GS, et al. Complete blood count reference interval diagrams derived from NHANES III: Stratification by age, sex, and race. Lab Hematol. 2004;10:42-53.

[19] Chen PC, Sung FC, Chien KL, et al. Red blood cell distribution width and risk of cardiovascular events and mortality in a community cohort in Taiwan. Am J Epidemiol. 2010;171:214-220.

[20] Qiao R, Yang S, Yao B, et al. Complete blood count reference intervals and age- and sex-related trends of North China Han population. Clin Chem Lab Med. 2014;52:1025-1032.

[21] Furuncuoglu Y, Tulgar S, Dogan AN, et al. How obesity affects the neutrophil/ lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: A retrospective study. Eur Rev Med Pharmacol Sci. 2016;20:1300-1306.

[22] Loprinzi PD, Hall ME. Physical activity and dietary behavior with red blood cell distribution width. PhysiolBehav. 2015;149:35-38.

[23] Ye Z, Smith C, Kullo IJ. Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease. Am J Cardiol. 2011;107:1241-1245.

[24] Osadnik T, Strzelczyk J, Hawranek M, et al. Red cell distribution width is associated with longterm prognosis in patients with stable coronary artery disease. BMC Cardiovasc Disord. 2013;13:113.

[25] Uyarel H, Ergelen M, Cicek G, et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis. 2011;22:138-144.

[26] Fatemi O, Paranilam J, Rainow A, et al. Red cell distribution width is a predictor of mortality in patients undergoing percutaneous coronary intervention. J Thromb Thrombolysis. 2013;35:57-64.

[27] Rechavi G, Rivella S. Regulation of iron absorption in hemoglobinopathies. Curr Mol Med. 2008;8:646-662.

[28] Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques:potential implications for inflammation and plaque instability. Circulation. 2000;101:1372-1378.